Caina Technology Co. Ltd. - Asset Resilience Ratio
Caina Technology Co. Ltd. (301122) has an Asset Resilience Ratio of 19.74% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Caina Technology Co. Ltd.'s Asset Resilience Ratio has changed over time. See 301122 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down Caina Technology Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 301122 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥441.52 Million | 19.74% |
| Total Liquid Assets | CN¥441.52 Million | 19.74% |
Asset Resilience Insights
- Good Liquidity Position: Caina Technology Co. Ltd. maintains a healthy 19.74% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Caina Technology Co. Ltd. Industry Peers by Asset Resilience Ratio
Compare Caina Technology Co. Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 4.32% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
Annual Asset Resilience Ratio for Caina Technology Co. Ltd. (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Caina Technology Co. Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 21.69% | CN¥435.11 Million ≈ $63.67 Million |
CN¥2.01 Billion ≈ $293.53 Million |
-11.00pp |
| 2024-12-31 | 32.69% | CN¥647.52 Million ≈ $94.75 Million |
CN¥1.98 Billion ≈ $289.87 Million |
-11.79pp |
| 2023-12-31 | 44.48% | CN¥858.03 Million ≈ $125.56 Million |
CN¥1.93 Billion ≈ $282.29 Million |
-3.91pp |
| 2022-12-31 | 48.39% | CN¥892.02 Million ≈ $130.53 Million |
CN¥1.84 Billion ≈ $269.74 Million |
+41.02pp |
| 2021-12-31 | 7.37% | CN¥45.17 Million ≈ $6.61 Million |
CN¥612.62 Million ≈ $89.65 Million |
-- |
About Caina Technology Co. Ltd.
Caina Technology Co., Ltd. engages in the research, development, production, and sale of plastic particles, needle holders, needle tubes, rubber plugs and other packaging materials. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. Caina T… Read more